What was the primary driver of the significant increase in total assets and liabilities?

The primary driver was the acquisition of Wella AG in September 2003, which involved a purchase price of approximately $5.1 billion. This acquisition led to a substantial increase in both assets (including goodwill and intangible assets) and liabilities (including short-term debt to finance the acquisition).

How did the Wella acquisition impact the financial statements for this quarter?

The Wella acquisition was accounted for as a purchase business combination and its results are included in the consolidated financial statements from September 2, 2003. It significantly boosted net sales and volume in the Beauty Care segment. The acquisition also led to a large increase in goodwill and intangible assets on the balance sheet and a significant use of cash in investing activities for the quarter.

What is the outlook for earnings growth, considering the Wella acquisition and ongoing operational factors?

The company reported strong double-digit growth in sales and earnings for the quarter. While the Wella acquisition is expected to contribute positively, management noted that business and market uncertainties could affect future results. The company highlighted lower manufacturing costs, benefits from completed restructuring, and marketing investments as key factors influencing earnings. For the Health Care segment specifically, while the Prilosec OTC launch was a strong contributor, future quarterly results are expected to normalize to consumption levels.

How has the company's cash flow position changed compared to the prior year?

Cash flow from operations decreased to $1.61 billion from $2.01 billion year-over-year, mainly due to increased working capital and timing differences. However, financing activities provided significant cash inflow of $1.96 billion compared to an outflow of $0.52 billion in the prior year, largely due to the issuance of short-term debt to fund the Wella acquisition. Overall, the company's cash and cash equivalents decreased by $1.86 billion during the quarter, ending at $4.05 billion.

PG 10-Q Quarterly Report Q1 FY2004 — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-Q filed October 28, 2003. Cited figures are marked; the original filing is the authoritative source.

Procter & Gamble reported strong performance for the first quarter of fiscal year 2004, with net sales increasing 13% to $12.2 billion^a and net earnings rising 20% to $1.76 billion.

This growth was driven by a 12% increase in unit volume across all business segments and geographic regions, aided by double-digit growth in the Health Care and Beauty Care segments. Diluted earnings per share saw a significant increase of 21% to $1.26^b.

The most notable event during the quarter was the acquisition of an 81% controlling interest in Wella AG for approximately $5.1 billion^c, which has been accounted for as a purchase business combination and is expected to contribute to the Beauty Care segment. Despite the significant investment and associated costs, the company demonstrated robust operational performance with improved gross margins and operating margins, reflecting effective cost management and benefits from completed restructuring programs.

02—Key points

Key Highlights

Net sales increased by 13% to $12.2 billion, driven by a 12% rise in unit volume.
Net earnings grew by 20% to $1.76 billion, with diluted earnings per share up 21% to $1.26.
The company completed the acquisition of an 81% controlling interest in Wella AG for approximately $5.1 billion, adding to the Beauty Care segment.
Gross margin improved by 260 basis points to 51.8%, attributed to lower cost of products sold and savings from completed restructuring programs.
Operating margin increased by 150 basis points to 21.7%.
Cash generated from operating activities was $1.61 billion, though lower than the prior year period due to increases in working capital.
Investing activities used $5.30 billion primarily due to the Wella acquisition, a significant increase from the prior year.

03—Questions

Frequently Asked Questions

What was the primary driver of the significant increase in total assets and liabilities?
The primary driver was the acquisition of Wella AG in September 2003, which involved a purchase price of approximately $5.1 billion. This acquisition led to a substantial increase in both assets (including goodwill and intangible assets) and liabilities (including short-term debt to finance the acquisition).
How did the Wella acquisition impact the financial statements for this quarter?
The Wella acquisition was accounted for as a purchase business combination and its results are included in the consolidated financial statements from September 2, 2003. It significantly boosted net sales and volume in the Beauty Care segment. The acquisition also led to a large increase in goodwill and intangible assets on the balance sheet and a significant use of cash in investing activities for the quarter.
What is the outlook for earnings growth, considering the Wella acquisition and ongoing operational factors?
The company reported strong double-digit growth in sales and earnings for the quarter. While the Wella acquisition is expected to contribute positively, management noted that business and market uncertainties could affect future results. The company highlighted lower manufacturing costs, benefits from completed restructuring, and marketing investments as key factors influencing earnings. For the Health Care segment specifically, while the Prilosec OTC launch was a strong contributor, future quarterly results are expected to normalize to consumption levels.
How has the company's cash flow position changed compared to the prior year?
Cash flow from operations decreased to $1.61 billion from $2.01 billion year-over-year, mainly due to increased working capital and timing differences. However, financing activities provided significant cash inflow of $1.96 billion compared to an outflow of $0.52 billion in the prior year, largely due to the issuance of short-term debt to fund the Wella acquisition. Overall, the company's cash and cash equivalents decreased by $1.86 billion during the quarter, ending at $4.05 billion.

04—Continue

← View all 10-Q filings